Form 4 for IDXX Idexx Laboratories
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001567619-21-015280 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-12 | 2021-08-10 | IDXX | Hunt Nimrata | EVP | M - OptEx | $90.32 | +1,106 | 9,212 | +14% | +$99.9K |
| DM | 2021-08-12 | 2021-08-10 | IDXX | Hunt Nimrata | EVP | M - OptEx | — | -1,106 | 706 | -61% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | M | A | 769 | $67.85 | 8,875.28 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-10 | M | A | 337 | $141.60 | 9,212.28 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (right-to-buy) | 2021-08-10 | M | D | 769 | — | 0 | D | $67.85 · — to 2026-02-13 | 769 Common Stock | (F3) Not applicable. (F1) Grant of option to buy 1,906 shares of Issuer common stock that vested as to 30 shares on February 14, 2018, 365 shares on February 14, 2020, and as to the remainder on February 14, 2021. |
| 4 | Derivative | Incentive Stock Option (right-to-buy) | 2021-08-10 | M | D | 337 | — | 706 | D | $141.60 · — to 2027-02-13 | 337 Common Stock | (F3) Not applicable. (F2) Grant of option to buy 1,043 shares of Issuer common stock that vested as to 337 shares on February 14, 2021 and vests as to the remainder on February 14, 2022. |